Quxia Zhang
YOU?
Author Swipe
View article: Watch-and-wait strategy in patients with objective response after immuno-chemotherapy for locally recurrent nasopharyngeal carcinoma: a pilot study
Watch-and-wait strategy in patients with objective response after immuno-chemotherapy for locally recurrent nasopharyngeal carcinoma: a pilot study Open
View article: Delineation of clinical target volume in nasopharyngeal carcinoma
Delineation of clinical target volume in nasopharyngeal carcinoma Open
Radiotherapy is the mainstay treatment modality for nasopharyngeal carcinoma (NPC). Intensity-modulated radiation therapy (IMRT), as the standard technique, achieves the purpose of improving target coverage and better sparing of normal tis…
View article: Sparing concurrent chemotherapy in low-risk locoregionally advanced nasopharyngeal carcinoma: A retrospective study from real-world experience
Sparing concurrent chemotherapy in low-risk locoregionally advanced nasopharyngeal carcinoma: A retrospective study from real-world experience Open
Objectives This study aims to explore the feasibility of sparing concurrent chemotherapy (CCT) after induction chemotherapy (ICT) in low-risk locoregionally advanced nasopharyngeal carcinoma (LANPC). Materials and methods LANPC patients(ex…
View article: Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study
Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study Open
Objective The immune inflammation-based score is recognized as a prognostic marker for cancer. However, the most accurate prognostic marker for patients with gastric cancer remains undetermined. We aimed to evaluate the predictive value of…
View article: Syndecan 4-c-ros oncogene 1 fusion as a mechanism of acquired resistance in epidermal growth factor receptor mutant lung adenocarcinoma
Syndecan 4-c-ros oncogene 1 fusion as a mechanism of acquired resistance in epidermal growth factor receptor mutant lung adenocarcinoma Open
To the Editor: A 37-year-old Chinese woman, a non-smoker, presented with adenocarcinoma of the left lung (stage IV) [Figure 1A], malignant pleural effusion, and multiple bone metastases in December 2014. Deoxyribonucleic acid sequencing of…
View article: Effect of icotinib on advanced lung adenocarcinoma patients with sensitive EGFR mutation detected in ctDNA by ddPCR
Effect of icotinib on advanced lung adenocarcinoma patients with sensitive EGFR mutation detected in ctDNA by ddPCR Open
Patients with sensitive EGFR mutations in plasma specimens detected with ddPCR had a higher ORR and DCR compared with patients with sensitive EGFR mutations in tissue detected with the ARMS method.
View article: Comparison of Rearranged During Transfection (RET) Gene Rearrangements in Primary Versus Metastatic Non-Small Cell Lung Cancer (NSCLC)
Comparison of Rearranged During Transfection (RET) Gene Rearrangements in Primary Versus Metastatic Non-Small Cell Lung Cancer (NSCLC) Open
BACKGROUND RET rearrangements have been reported in 30% of papillary thyroid carcinomas and 1-2% of non-small cell lung cancer (NSCLC). In these tumors, RET gene fusion product provides a constitutively active tyrosine kinase (TKR), leadin…
View article: Intestinal metastasis from primary<em> ROS1</em>-positive lung adenocarcinoma cancer patients responding to crizotinib
Intestinal metastasis from primary<em> ROS1</em>-positive lung adenocarcinoma cancer patients responding to crizotinib Open
Small intestinal metastases from primary lung cancer are rare. Such patients have a poor prognosis. Early diagnosis of small intestinal metastases is difficult because of the low incidence of clinically apparent symptoms. The standard trea…
View article: MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma
MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma Open